Noah Labs
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $3.0Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2025-06-01attributed |
| Founded | 2021 |
| Headquarters | Berlin, Germany |
| Industry | healthtech |
| Stage | unknown |
| Website | noahlabs.com |
Noah Labs runs the Ark Class IIa telemonitoring software plus the Vox voice-biomarker algorithm that detects worsening heart failure weeks before hospitalisation. Customers include cardiology programmes managing heart failure, hypertension, and arrhythmia. Vox holds FDA Breakthrough Device designation and the company has been selected for an EIC Accelerator package of up to €11M.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-06-01 | grant | $2.7M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $3.0M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | noahlabs.com, read 2026-05-08 |
| Description | self-reported | noahlabs.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.